| Identification | Back Directory | [Name]
ReMogliflozin etabonate | [CAS]
442201-24-3 | [Synonyms]
EOS-61714
GSK 189075
ReMogliflozin etabonate
UAOCLDQAQNNEAX-ABMICEGHSA-N
β-D-Glucopyranoside, 5-methyl-4-[[4-(1-methylethoxy)phenyl]methyl]-1-(1-methylethyl)-1H-pyrazol-3-yl, 6-(ethyl carbonate)
ethyl [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-methyl-1-propan-2-yl-4-[(4-propan-2-yloxyphenyl)methyl]pyrazol-3-yl]oxyoxan-2-yl]methyl carbonate
ethyl(((2R,3S,4S,5R,6S)-6-((4-(4-isopropoxybenzyl)-1-isopropyl-5-methyl-1H-pyrazol-3-yl)oxy)-3,4,5-tri(l1-oxidanyl)tetrahydro-2H-pyran-2-yl)methyl)carbonateGSK-189075 | [Molecular Formula]
C26H38N2O9 | [MDL Number]
MFCD17167013 | [MOL File]
442201-24-3.mol | [Molecular Weight]
522.6 |
| Chemical Properties | Back Directory | [Boiling point ]
661.3±55.0 °C(Predicted) | [density ]
1.31±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: Soluble; Methanol: Soluble | [form ]
A solid | [pka]
12.58±0.70(Predicted) |
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|